Document Detail

Acute lipoprotein changes associated with atenolol therapy for hypertension in non-insulin dependent diabetes.
MedLine Citation:
PMID:  3236327     Owner:  NLM     Status:  MEDLINE    
In a study on 11 stable hypertensive non-insulin dependent diabetic subjects the influence of beta-blocker (atenolol 100mg) withdrawal and reintroduction was assessed. After a three week placebo phase significant increases in pulse rate, high density lipoprotein- and high density lipoprotein2-cholesterol and a significant decrease in triglyceride were observed. Three weeks after recommencement of atenolol therapy the pulse, lipid and lipoprotein changes were reversed and significantly so. Weight and blood pressure remained constant throughout. Results from this study indicate that in non-insulin dependent diabetes, atenolol-induced lipid and lipoprotein changes are reversible in the short term and occur in the absence of significant changes in blood pressure control. The lipoprotein changes observed involved an alteration in high density lipoprotein composition. As a reduced high density lipoprotein cholesterol is associated with macrovascular disease, future studies on the association of lipoproteins and diabetic complications should take into account these changes in lipoproteins with beta-blocker hypotensive therapy.
M D Feher; D J Torrens; W Richmond; J Wadsworth; P S Sever; R S Elkeles
Related Documents :
3401287 - Further resolution and comparison of the heterogeneity of plasma low-density lipoprotei...
9839097 - Ldl size distribution in relation to insulin sensitivity and lipoprotein pattern in you...
6788567 - Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabol...
15969877 - Antioxidant effect of atorvastatin is independent of pon1 gene t(-107)c, q192r and l55m...
2168587 - Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst:...
25249577 - Intranasal insulin enhanced resting-state functional connectivity of hippocampal region...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of human hypertension     Volume:  2     ISSN:  0950-9240     ISO Abbreviation:  J Hum Hypertens     Publication Date:  1988 Dec 
Date Detail:
Created Date:  1989-05-02     Completed Date:  1989-05-02     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8811625     Medline TA:  J Hum Hypertens     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  253-5     Citation Subset:  IM    
Department of Clinical Pharmacology, St. Mary's Hospital Medical School, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atenolol / therapeutic use*
Diabetes Mellitus, Type 2 / blood,  complications,  metabolism*
Hypertension / blood,  complications,  drug therapy*
Lipoproteins / blood,  metabolism*
Middle Aged
Reg. No./Substance:
0/Lipoproteins; 29122-68-7/Atenolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antihypertensive therapy and cardiovascular reactivity during isometric stress.
Next Document:  Antihypertensive effect of diltiazem administered once and twice daily.